// App-Quantinova.ai

PB0086 : Haemostatic differences between SARS-CoV-2 PCR-positive and -negative patients at the time of hospital admission

Researchers

Presenter

  • J. Remijn

Principal Investigators

  • R. de Laat-Kremers

  • S. Verweij

  • M. Ninivaggi

  • D. Huskens

  • A. Miszta

  • R. Nijhuis

  • R. Fijnheer

  • M. Roest

  • B. de Laat

Medical Centers

  • Department of Clinical Chemistry. Meander Medical Center, Amersfoort, Amersfoort, Utrecht, Netherlands

  • Department of Clinical Chemistry. Meander Medical Center, Amersfoort, Amersfoort, Utrecht, Netherlands

  • Synapse Research Institute, Maastricht, the Netherlands

  • Synapse Research Institute, Maastricht, the Netherlands, Maastricht, Limburg, Netherlands

  • Department of Medical Microbiology and Medical Immunology. Meander Medical Center, Amersfoort, Amersfoort, Utrecht, Netherlands

  • Department of Pulmonology. Meander Medical Center, Amersfoort, Amersfoort, Utrecht, Netherlands

  • Department of Functional Coagulation, Synapse Research Institute, Maastricht, the Netherlands;, Maastricht, Limburg, Netherlands

Locations

  • Netherlands

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

  • Pulmonary/Respiratory Diseases

  • Infectious Diseases (ID)

  • Blood/haematological Diseases

Disease

  • Venous thrombosis

  • Coronavirus disease

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A


Study Design

  • Cross-Sectional

  • Cohort

  • Single Center

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A